#AUROPHARMA US FDA EIR Received:

Aurobindo Pharma's Unit 2 of Apitoria Pharma Pvt. Ltd. received an Establishment Inspection Report from the US FDA with a Voluntary Action Indicated classification after an inspection from September 23 to 27, 2024.